Biotech

Some of the biggest biotechnology winners of 2017 so far are cannabis stocks. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a $3 billion pharmaceutical cannabis company and probably the most well known company in this subsector of healthcare, is up around 7% since the start of the year. Zynerba Pharmaceuticals Inc...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Intellia Therapeutics Inc. (NASDAQ:NTLA) reported that Caribou Biosciences, Inc. has picked up 5,593,846 of common stock as of 2017-02-28. The acquisition brings the aggregate amount owned by Caribou Biosciences, Inc. to a total of 5,593,846 ...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Exelixis Inc. (NASDAQ:EXEL) reported that 1globe Capital Llc. has picked up 5,437,285 of common stock as of 2017-02-15. The acquisition brings the aggregate amount owned by 1globe Capital Llc. to a total of 5,437,285 representing...

Dr. Phillip Frost is one of the most respected and well known entrepreneurs in biotech. He's made billions of dollars founding, running and selling pharmaceutical companies, and he's currently the CEO and Chairman of Opko Health Inc. (NASDAQ:OPK), the $6 billion diagnostics and pharmaceuticals behemoth. He's overseen the development of...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Photomedex Inc (NASDAQ:PHMD) reported that Pell Lewis C has picked up 424,064 of common stock as of 2017-05-01. The acquisition brings the aggregate amount owned by Pell Lewis C to a total of 424,064 representing...